Pharming Group reports second quarter and first half 2025 financial results and provides business update | Morningstar

Second quarter 2025 total revenues increased by 26% to US$93.2 million, compared to the second quarter 2024, driven by strong RUCONEST and Joenja revenue growth RUCONEST second quarter revenue increased by 28% to US$80.4 million, compare
Read more...